{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1360004235508133248.json","@type":"Article","productIdentifier":[{"identifier":{"@type":"DOI","@value":"10.1111/ejh.12856"}},{"identifier":{"@type":"URI","@value":"https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fejh.12856"}},{"identifier":{"@type":"URI","@value":"https://onlinelibrary.wiley.com/doi/pdf/10.1111/ejh.12856"}},{"identifier":{"@type":"PMID","@value":"28129454"}}],"resourceType":"学術雑誌論文(journal article)","dc:title":[{"@value":"Comparison of clinicopathological characteristics between T‐cell prolymphocytic leukemia and peripheral T‐cell lymphoma, not otherwise specified"}],"description":[{"type":"abstract","notation":[{"@value":"<jats:title>Abstract</jats:title><jats:sec><jats:title>Objectives</jats:title><jats:p>T‐cell prolymphocytic leukemia (T‐<jats:styled-content style=\"fixed-case\">PLL</jats:styled-content>) is a very rare, aggressive T‐cell neoplasm. Peripheral T‐cell lymphoma, not otherwise specified (<jats:styled-content style=\"fixed-case\">PTCL</jats:styled-content>‐<jats:styled-content style=\"fixed-case\">NOS</jats:styled-content>) is also a highly aggressive lymphoma. These two diseases can often be confused with each other; therefore, we aimed to determine the clinical and pathological differences between T‐<jats:styled-content style=\"fixed-case\">PLL</jats:styled-content>and<jats:styled-content style=\"fixed-case\">PTCL</jats:styled-content>‐<jats:styled-content style=\"fixed-case\">NOS</jats:styled-content>.</jats:p></jats:sec><jats:sec><jats:title>Methods</jats:title><jats:p>We analyzed 15 T‐<jats:styled-content style=\"fixed-case\">PLL</jats:styled-content>and 91<jats:styled-content style=\"fixed-case\">PTCL</jats:styled-content>‐<jats:styled-content style=\"fixed-case\">NOS</jats:styled-content>patients and also compared clinical features between T‐<jats:styled-content style=\"fixed-case\">PLL</jats:styled-content>and<jats:styled-content style=\"fixed-case\">PTCL</jats:styled-content>‐<jats:styled-content style=\"fixed-case\">NOS</jats:styled-content>with leukemic presentation. Peripheral blood images and biopsy specimens were analyzed, and treatment responses were determined via imaging modalities. The clinicopathological characteristics were statistically compared.</jats:p></jats:sec><jats:sec><jats:title>Results</jats:title><jats:p>T‐PLL cells were smaller in size than those of<jats:styled-content style=\"fixed-case\">PTCL</jats:styled-content>‐<jats:styled-content style=\"fixed-case\">NOS</jats:styled-content>with leukemic presentation (<jats:italic>P</jats:italic>=.0068); moreover,<jats:styled-content style=\"fixed-case\">PTCL</jats:styled-content>‐<jats:styled-content style=\"fixed-case\">NOS</jats:styled-content>cells with leukemic presentation were smaller than those of<jats:styled-content style=\"fixed-case\">PTCL</jats:styled-content>‐<jats:styled-content style=\"fixed-case\">NOS</jats:styled-content>without leukemic presentation (<jats:italic>P</jats:italic>=.0017). Immunophenotypic patterns in T‐<jats:styled-content style=\"fixed-case\">PLL</jats:styled-content>and<jats:styled-content style=\"fixed-case\">PTCL</jats:styled-content>‐<jats:styled-content style=\"fixed-case\">NOS</jats:styled-content>were similar. Five‐year overall survival rates of T‐<jats:styled-content style=\"fixed-case\">PLL</jats:styled-content>and all<jats:styled-content style=\"fixed-case\">PTCL</jats:styled-content>‐<jats:styled-content style=\"fixed-case\">NOS</jats:styled-content>patients were 57.5% and 36.8%, respectively. No significant differences were found in clinical manifestations or prognoses; T‐<jats:styled-content style=\"fixed-case\">PLL</jats:styled-content>and<jats:styled-content style=\"fixed-case\">PTCL</jats:styled-content>‐<jats:styled-content style=\"fixed-case\">NOS</jats:styled-content>with leukemic presentation had essentially equivalent characteristics.</jats:p></jats:sec><jats:sec><jats:title>Conclusion</jats:title><jats:p>T‐PLL and<jats:styled-content style=\"fixed-case\">PTCL</jats:styled-content>‐<jats:styled-content style=\"fixed-case\">NOS</jats:styled-content>may share common biological and clinical characteristics in Japanese patients.</jats:p></jats:sec>"}]}],"creator":[{"@id":"https://cir.nii.ac.jp/crid/1380004235508133376","@type":"Researcher","foaf:name":[{"@value":"Keisuke Kawamoto"}],"jpcoar:affiliationName":[{"@value":"Department of Pathology School of Medicine Kurume University Kurume Japan"},{"@value":"Department of Hematology, Endocrinology, and Metabolism Faculty of Medicine Niigata University Niigata Japan"}]},{"@id":"https://cir.nii.ac.jp/crid/1420001326230916608","@type":"Researcher","personIdentifier":[{"@type":"KAKEN_RESEARCHERS","@value":"30647780"},{"@type":"NRID","@value":"1000030647780"},{"@type":"NRID","@value":"9000283540439"},{"@type":"NRID","@value":"9000342449320"},{"@type":"NRID","@value":"9000359904516"},{"@type":"NRID","@value":"9000019061265"},{"@type":"NRID","@value":"9000018281249"},{"@type":"NRID","@value":"9000326268179"},{"@type":"NRID","@value":"9000362189103"},{"@type":"NRID","@value":"9000399760067"},{"@type":"NRID","@value":"9000402798519"},{"@type":"NRID","@value":"9000261669267"},{"@type":"NRID","@value":"9000296662978"},{"@type":"NRID","@value":"9000396109505"},{"@type":"NRID","@value":"9000249500639"},{"@type":"NRID","@value":"9000366497567"},{"@type":"NRID","@value":"9000360588250"},{"@type":"NRID","@value":"9000403424492"},{"@type":"NRID","@value":"9000402249497"},{"@type":"NRID","@value":"9000402249543"},{"@type":"NRID","@value":"9000006344572"},{"@type":"NRID","@value":"9000399603820"},{"@type":"NRID","@value":"9000261669114"},{"@type":"NRID","@value":"9000336038625"},{"@type":"NRID","@value":"9000399222420"},{"@type":"NRID","@value":"9000399222389"},{"@type":"NRID","@value":"9000006898731"},{"@type":"NRID","@value":"9000311769399"},{"@type":"NRID","@value":"9000397960243"},{"@type":"NRID","@value":"9000403995205"},{"@type":"RESEARCHMAP","@value":"https://researchmap.jp/miyoshi_hiroaki"}],"foaf:name":[{"@value":"Hiroaki Miyoshi"}],"jpcoar:affiliationName":[{"@value":"Department of Pathology School of Medicine Kurume University Kurume Japan"}]},{"@id":"https://cir.nii.ac.jp/crid/1380004235508133132","@type":"Researcher","foaf:name":[{"@value":"Eriko Yanagida"}],"jpcoar:affiliationName":[{"@value":"Department of Pathology School of Medicine Kurume University Kurume Japan"}]},{"@id":"https://cir.nii.ac.jp/crid/1380004235508133129","@type":"Researcher","foaf:name":[{"@value":"Noriaki Yoshida"}],"jpcoar:affiliationName":[{"@value":"Department of Pathology School of Medicine Kurume University Kurume Japan"}]},{"@id":"https://cir.nii.ac.jp/crid/1380004235508133248","@type":"Researcher","foaf:name":[{"@value":"Junichi Kiyasu"}],"jpcoar:affiliationName":[{"@value":"Department of Hematology Iizuka Hospital Iizuka Japan"}]},{"@id":"https://cir.nii.ac.jp/crid/1380004235508133125","@type":"Researcher","foaf:name":[{"@value":"Yasuji Kozai"}],"jpcoar:affiliationName":[{"@value":"Department of Hematology Tokyo Metropolitan Tama Medical Center Fuchu Japan"}]},{"@id":"https://cir.nii.ac.jp/crid/1380004235508133133","@type":"Researcher","foaf:name":[{"@value":"Tatsuma Morikita"}],"jpcoar:affiliationName":[{"@value":"Division of Medical Oncology Saiseikai Kumamoto Hospital Kumamoto Japan"}]},{"@id":"https://cir.nii.ac.jp/crid/1380004235508133380","@type":"Researcher","foaf:name":[{"@value":"Takeharu Kato"}],"jpcoar:affiliationName":[{"@value":"Department of Hematology Sasebo City General Hospital Sasebo Japan"}]},{"@id":"https://cir.nii.ac.jp/crid/1380004235508133260","@type":"Researcher","foaf:name":[{"@value":"Hitoshi Suzushima"}],"jpcoar:affiliationName":[{"@value":"Department of Hematology Kumamoto Shinto General Hospital Kumamoto Japan"}]},{"@id":"https://cir.nii.ac.jp/crid/1380004235508133251","@type":"Researcher","foaf:name":[{"@value":"Shinobu Tamura"}],"jpcoar:affiliationName":[{"@value":"Department of Hematology and Oncology Wakayama Medical University Wakayama Japan"}]},{"@id":"https://cir.nii.ac.jp/crid/1380004235508133252","@type":"Researcher","foaf:name":[{"@value":"Tsuyoshi Muta"}],"jpcoar:affiliationName":[{"@value":"Department of Hematology Japan Community Health Care Organization Kyushu Hospital Kitakyushu Japan"}]},{"@id":"https://cir.nii.ac.jp/crid/1380004235508133120","@type":"Researcher","foaf:name":[{"@value":"Koji Kato"}],"jpcoar:affiliationName":[{"@value":"Department of Medicine and Biosystemic Science Kyushu University Graduate School of Medical Sciences Fukuoka Japan"}]},{"@id":"https://cir.nii.ac.jp/crid/1380004235508133121","@type":"Researcher","foaf:name":[{"@value":"Tetsuya Eto"}],"jpcoar:affiliationName":[{"@value":"Department of Hematology Hamanomachi Hospital Fukuoka Japan"}]},{"@id":"https://cir.nii.ac.jp/crid/1380004235508133126","@type":"Researcher","foaf:name":[{"@value":"Ritsuko Seki"}],"jpcoar:affiliationName":[{"@value":"Department of Hematology and Oncology School of Medicine Kurume University Kurume Japan"}]},{"@id":"https://cir.nii.ac.jp/crid/1420564276164941056","@type":"Researcher","personIdentifier":[{"@type":"KAKEN_RESEARCHERS","@value":"60343323"},{"@type":"NRID","@value":"1000060343323"},{"@type":"NRID","@value":"9000015253126"},{"@type":"NRID","@value":"9000399551710"},{"@type":"NRID","@value":"9000021930820"},{"@type":"NRID","@value":"9000398785205"},{"@type":"NRID","@value":"9000021259600"},{"@type":"NRID","@value":"9000345346323"},{"@type":"NRID","@value":"9000010677237"},{"@type":"NRID","@value":"9000018761568"},{"@type":"NRID","@value":"9000411505276"},{"@type":"NRID","@value":"9000002150254"},{"@type":"NRID","@value":"9000317563985"},{"@type":"NRID","@value":"9000363359004"},{"@type":"NRID","@value":"9000255316020"},{"@type":"NRID","@value":"9000403168944"},{"@type":"NRID","@value":"9000241860441"},{"@type":"NRID","@value":"9000018874731"},{"@type":"NRID","@value":"9000390878841"},{"@type":"NRID","@value":"9000254054120"},{"@type":"NRID","@value":"9000403273659"},{"@type":"NRID","@value":"9000018840012"},{"@type":"NRID","@value":"9000337084757"},{"@type":"NRID","@value":"9000404145436"},{"@type":"NRID","@value":"9000258035164"},{"@type":"NRID","@value":"9000337089700"},{"@type":"NRID","@value":"9000368405407"},{"@type":"NRID","@value":"9000283533831"},{"@type":"NRID","@value":"9000309173145"},{"@type":"NRID","@value":"9000388465862"},{"@type":"NRID","@value":"9000399498596"},{"@type":"NRID","@value":"9000258036089"},{"@type":"NRID","@value":"9000258038795"},{"@type":"NRID","@value":"9000015192222"}],"foaf:name":[{"@value":"Koji Nagafuji"}],"jpcoar:affiliationName":[{"@value":"Department of Hematology and Oncology School of Medicine Kurume University Kurume Japan"}]},{"@id":"https://cir.nii.ac.jp/crid/1380004235508133134","@type":"Researcher","foaf:name":[{"@value":"Hirohito Sone"}],"jpcoar:affiliationName":[{"@value":"Department of Hematology, Endocrinology, and Metabolism Faculty of Medicine Niigata University Niigata Japan"}]},{"@id":"https://cir.nii.ac.jp/crid/1380004235508133383","@type":"Researcher","foaf:name":[{"@value":"Jun Takizawa"}],"jpcoar:affiliationName":[{"@value":"Department of Hematology, Endocrinology, and Metabolism Faculty of Medicine Niigata University Niigata Japan"}]},{"@id":"https://cir.nii.ac.jp/crid/1380004235508133384","@type":"Researcher","foaf:name":[{"@value":"Masao Seto"}],"jpcoar:affiliationName":[{"@value":"Department of Pathology School of Medicine Kurume University Kurume Japan"}]},{"@id":"https://cir.nii.ac.jp/crid/1380004235508133389","@type":"Researcher","foaf:name":[{"@value":"Koichi Ohshima"}],"jpcoar:affiliationName":[{"@value":"Department of Pathology School of Medicine Kurume University Kurume Japan"}]}],"publication":{"publicationIdentifier":[{"@type":"PISSN","@value":"09024441"},{"@type":"EISSN","@value":"16000609"}],"prism:publicationName":[{"@value":"European Journal of Haematology"}],"dc:publisher":[{"@value":"Wiley"}],"prism:publicationDate":"2017-03-03","prism:volume":"98","prism:number":"5","prism:startingPage":"459","prism:endingPage":"466"},"reviewed":"false","dc:rights":["http://onlinelibrary.wiley.com/termsAndConditions#vor"],"url":[{"@id":"https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fejh.12856"},{"@id":"https://onlinelibrary.wiley.com/doi/pdf/10.1111/ejh.12856"}],"createdAt":"2017-01-27","modifiedAt":"2024-06-22","foaf:topic":[{"@id":"https://cir.nii.ac.jp/all?q=Adult","dc:title":"Adult"},{"@id":"https://cir.nii.ac.jp/all?q=Male","dc:title":"Male"},{"@id":"https://cir.nii.ac.jp/all?q=Adolescent","dc:title":"Adolescent"},{"@id":"https://cir.nii.ac.jp/all?q=Biopsy","dc:title":"Biopsy"},{"@id":"https://cir.nii.ac.jp/all?q=Receptors,%20Antigen,%20T-Cell","dc:title":"Receptors, Antigen, T-Cell"},{"@id":"https://cir.nii.ac.jp/all?q=Immunophenotyping","dc:title":"Immunophenotyping"},{"@id":"https://cir.nii.ac.jp/all?q=Diagnosis,%20Differential","dc:title":"Diagnosis, Differential"},{"@id":"https://cir.nii.ac.jp/all?q=Leukocyte%20Count","dc:title":"Leukocyte Count"},{"@id":"https://cir.nii.ac.jp/all?q=Young%20Adult","dc:title":"Young Adult"},{"@id":"https://cir.nii.ac.jp/all?q=Antineoplastic%20Combined%20Chemotherapy%20Protocols","dc:title":"Antineoplastic Combined Chemotherapy Protocols"},{"@id":"https://cir.nii.ac.jp/all?q=Humans","dc:title":"Humans"},{"@id":"https://cir.nii.ac.jp/all?q=Neoplasm%20Metastasis","dc:title":"Neoplasm Metastasis"},{"@id":"https://cir.nii.ac.jp/all?q=Child","dc:title":"Child"},{"@id":"https://cir.nii.ac.jp/all?q=Aged","dc:title":"Aged"},{"@id":"https://cir.nii.ac.jp/all?q=Neoplasm%20Staging","dc:title":"Neoplasm Staging"},{"@id":"https://cir.nii.ac.jp/all?q=Aged,%2080%20and%20over","dc:title":"Aged, 80 and over"},{"@id":"https://cir.nii.ac.jp/all?q=Gene%20Rearrangement","dc:title":"Gene Rearrangement"},{"@id":"https://cir.nii.ac.jp/all?q=Lymphoma,%20T-Cell,%20Peripheral","dc:title":"Lymphoma, T-Cell, Peripheral"},{"@id":"https://cir.nii.ac.jp/all?q=Middle%20Aged","dc:title":"Middle Aged"},{"@id":"https://cir.nii.ac.jp/all?q=Prognosis","dc:title":"Prognosis"},{"@id":"https://cir.nii.ac.jp/all?q=Treatment%20Outcome","dc:title":"Treatment Outcome"},{"@id":"https://cir.nii.ac.jp/all?q=Leukemia,%20Prolymphocytic,%20T-Cell","dc:title":"Leukemia, Prolymphocytic, T-Cell"},{"@id":"https://cir.nii.ac.jp/all?q=Female","dc:title":"Female"},{"@id":"https://cir.nii.ac.jp/all?q=Biomarkers","dc:title":"Biomarkers"}],"project":[{"@id":"https://cir.nii.ac.jp/crid/1040000781915628032","@type":"Project","projectIdentifier":[{"@type":"KAKEN","@value":"16K09883"},{"@type":"JGN","@value":"JP16K09883"},{"@type":"URI","@value":"https://kaken.nii.ac.jp/grant/KAKENHI-PROJECT-16K09883/"}],"notation":[{"@language":"ja","@value":"造血幹細胞移植への応用に向けた次世代シーケンサーによる新規マイナー組織抗原の解析"},{"@language":"en","@value":"Identification of novel minor histocompatibility antigens by next-generation sequencing in allogeneic stem cell transplantation patients"}]},{"@id":"https://cir.nii.ac.jp/crid/1040282256902254336","@type":"Project","projectIdentifier":[{"@type":"KAKEN","@value":"16K19093"},{"@type":"JGN","@value":"JP16K19093"},{"@type":"URI","@value":"https://kaken.nii.ac.jp/grant/KAKENHI-PROJECT-16K19093/"}],"notation":[{"@language":"ja","@value":"末梢性T細胞性リンパ腫におけるPD-L1発現の臨床病理学的意義"},{"@language":"en","@value":"Clinicopathological significance of PD-L1 expression in peripheral T-cell lymphoma"}]}],"relatedProduct":[{"@id":"https://cir.nii.ac.jp/crid/1360002218222085632","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Clinicopathological analysis of a composite lymphoma containing both T‐ and B‐cell lymphomas"}]},{"@id":"https://cir.nii.ac.jp/crid/1360011144880738944","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Indolent T‐cell prolymphocytic leukemia: A case report"}]},{"@id":"https://cir.nii.ac.jp/crid/1360285705108131200","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Frequent expression of <scp>CD</scp>30 in extranodal <scp>NK</scp>/<scp>T</scp>‐cell lymphoma: Potential therapeutic target for anti‐<scp>CD</scp>30 antibody‐based therapy"}]},{"@id":"https://cir.nii.ac.jp/crid/1360285714187575424","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Clinicopathological characteristics of follicular lymphoma with peripheral blood involvement"}]},{"@id":"https://cir.nii.ac.jp/crid/1360292621343641856","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"T‐cell chronic lymphocytic leukemia or small‐cell variant of T‐cell prolymphocytic leukemia: a historical perspective and search for consensus"}]},{"@id":"https://cir.nii.ac.jp/crid/1360567187317500160","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Clinicopathologic Analysis of Peripheral T-Cell Lymphoma, Follicular Variant, and Comparison With Angioimmunoblastic T-Cell Lymphoma"}]},{"@id":"https://cir.nii.ac.jp/crid/1360574096109165056","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Peripheral T-cell lymphoma"}]},{"@id":"https://cir.nii.ac.jp/crid/1360848656449821312","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"T-cell prolymphocytic leukemia in Japan: is it a variant?"}]},{"@id":"https://cir.nii.ac.jp/crid/1360855571136979072","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Expression of the <i>TCL1</i> Gene at 14q32 in B‐Cell Malignancies but Not in Adult T‐Cell Leukemia"}]},{"@id":"https://cir.nii.ac.jp/crid/1360855571502119040","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"TCRαβ+/CD4+ Large Granular Lymphocytosis"}]},{"@id":"https://cir.nii.ac.jp/crid/1361137043862195584","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Multiple karyotypic abnormalities in three cases of small cell variant of T-cell prolymphocytic leukemia"}]},{"@id":"https://cir.nii.ac.jp/crid/1361137045161383424","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Abnormalities of Chromosomes 8, 11, 14, and X in T-Prolymphocytic Leukemia Studied by Fluorescence In Situ Hybridization"}]},{"@id":"https://cir.nii.ac.jp/crid/1361137045168381440","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"TCL1A gene involvement in T-cell prolymphocytic leukemia in Japanese patients"}]},{"@id":"https://cir.nii.ac.jp/crid/1361418518599637248","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Heterogeneity of Epstein-Barr virus infection in angioimmunoblastic lymphadenopathy type T-cell lymphoma"}]},{"@id":"https://cir.nii.ac.jp/crid/1361418519578126976","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Cytogenetic studies on prolymphocytic leukemia. II. T cell prolymphocytic leukemia"}]},{"@id":"https://cir.nii.ac.jp/crid/1361699994881307008","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Marker Expression in Peripheral T-Cell Lymphoma: A Proposed Clinical-Pathologic Prognostic Score"}]},{"@id":"https://cir.nii.ac.jp/crid/1361699995114408064","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Trisomy 8q due to i(8q) or der(8) t(8;8) is a frequent lesion in T‐prolymphocytic leukaemia: four new cases and a review of the literature"}]},{"@id":"https://cir.nii.ac.jp/crid/1362262946207426432","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"The morphological spectrum of T‐prolymphocytic leukaemia"}]},{"@id":"https://cir.nii.ac.jp/crid/1362544418462040320","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Peripheral T-cell lymphoma, not otherwise specified: a report of 340 cases from the International Peripheral T-cell Lymphoma Project"}]},{"@id":"https://cir.nii.ac.jp/crid/1362825893735335168","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Unusually indolent T‐cell prolymphocytic leukemia associated with a complex karyotype: Is this T‐cell chronic lymphocytic leukemia?"}]},{"@id":"https://cir.nii.ac.jp/crid/1362825894080091008","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"T-cell non-Hodgkin lymphoma"}]},{"@id":"https://cir.nii.ac.jp/crid/1362825895236923136","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Investigation of the freely available easy-to-use software ‘EZR’ for medical statistics"}]},{"@id":"https://cir.nii.ac.jp/crid/1363107369133482112","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group [see comments]"}]},{"@id":"https://cir.nii.ac.jp/crid/1363107369931961856","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"A systematic approach to diagnosis of mature T-cell leukemias reveals heterogeneity among WHO categories"}]},{"@id":"https://cir.nii.ac.jp/crid/1363107370346045184","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Clinical and laboratory features of 78 cases of T-prolymphocytic leukemia"}]},{"@id":"https://cir.nii.ac.jp/crid/1363388846124862592","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"The leukaemic phase of non-Hodgkin's lymphoma."}]},{"@id":"https://cir.nii.ac.jp/crid/1363951794065431424","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"T-Cell Prolymphocytic Leukemia"}]},{"@id":"https://cir.nii.ac.jp/crid/1364233269420619136","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Campath-1H Treatment of T-Cell Prolymphocytic Leukemia in Patients for Whom at Least One Prior Chemotherapy Regimen Has Failed"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001204704637312","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Clinicopathological features of cryptococcal lymphadenitis and a review of literature"}]}],"dataSourceIdentifier":[{"@type":"CROSSREF","@value":"10.1111/ejh.12856"},{"@type":"KAKEN","@value":"PRODUCT-21237942"},{"@type":"KAKEN","@value":"PRODUCT-21917278"},{"@type":"OPENAIRE","@value":"doi_dedup___::9dc7e3ce8a1d400fc8bde4c00c9393ca"},{"@type":"CROSSREF","@value":"10.1002/hon.2482_references_DOI_GyUfnPZP5xkhVkeRtC9YQRDMcA2"},{"@type":"CROSSREF","@value":"10.3960/jslrt.17011_references_DOI_GyUfnPZP5xkhVkeRtC9YQRDMcA2"}]}